Can We Tame the Monster?
"Drug companies should not be allowed to evaluate their own products."
-
-
Controlled Trial: Antidepressants Useless to Treat Anorexia–Risk: 1 of 49 Attempted Suicide
A team of researchers from Columbia University and the University of Toronto, headed by Dr. Timothy Walsh (New York) tested the effect of antidepressants in the treatment of anorexia in a placebo controlled randomized trial.
-
“Do Antidepressants Cure or Create Abnormal Brain States?”
A provocative article by Dr. Joanna Moncrieff and Dr. David Cohen, PLOS Medicine, June 5.
-
Intermittent Explosive Disorder-a parody
It is difficult to believe this latest announcement laying claim to a new "under treated" psychiatric disorder–Intermittent Explosive Disorder (IED) is not a parody !!
-
GSK Reverses Decade of Denial: Paxil Triggered Suicide in Adults
GlaxoSmithKline Reverses Decade of Denial: in Clinical Trials Paxil Triggered Significantly More Suicide Attempts in Adults than Placebo
-
Disease Mongering_Conference / PLoS Special Issue
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
-
Psychiatry’s “Desperate Cures?” Electric Switches for Depression?
An OpEd in The New York Times (below) is trumpeting psychiatry’s latest “cure” for depression: it requires surgical implantation of electrodes in the brain, continued “maintenance” with powerful psychotropic drugs, and it costs $40,000.
-
Guinea Pig Gang: Meet U.S. Students Who Rent Their Bodies for Cash
A series of news reports may be a rude awakening to the fact that there are hidden, potentially lethal hazards of participating in clinical trials—and those hazards are concealed from the human guinea pigs who are enticed with promise of easy money.
-
National Class Action Filed against Drug-maker for Paxil-induced Suicides in Youths
Below a press release from the lawfirm, Baum Hedlund, announces it has filed a class action lawsuit against GlaxoSmithKline charging the company with fraud, negligence, strict liability, and breach of warranty in its marketing of Paxil (Seroxat) by concealing the risk of suicide.
-
FDA Psychopharm Advisory Chair Acknowledges No Evidence for SSRI Chemical Imbalance Claims_CMAJ
"Biological psychiatrists have looked very closely for a serotonin imbalance or dysfunction in patients with depression or obsessive compulsive disorder and, to date, it has been elusive," says Dr. Wayne Goodman, Chair of the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee.
-
Concealed Paxil Suicide Data Released after years under Court Seal
Dr. Peter Breggin’s sealed expert medical report in a Paxil liability case is now in the public domain.
-
‘Debate’- Case Against Scientific Validity of Mental Screens– NAS- Sci-Tech Policy Fellows Seminar
The importance of debate in science cannot be overstated. Without the challenge of debate, science is dominated by "authorities" who provide only the veneer of science without substance supported by evidence. Correct url for power point: https://ahrp.stagenoises.ch/children/teenscreen/debateNAS0206.ppt